VEGF in Iris Tissue in Primary Congenital Glaucoma

Iris Clinical Trial

Official title:
Estimation of Vascular Endothelial Growth Factor (VEGF) in Iris Tissue in Primary Congenital Glaucoma

Status Not yet recruiting

Clinical Trial Summary

Estimation of vascular endothelial growth factor (VEGF) in iris tissue specimen in primary congenital glaucoma through Immunohistochemistry.

Clinical Trial Description

Combined trabeculotomy with mitomycin C will done in infants with primary congenital glaucoma with histopathological examination of the the peripheral iris tissue specimen and vascular endothelial growth factor (VEGF) estimation in iris tissue specimen through Immunohistochemistry. Estimation of vascular endothelial growth factor (VEGF) in iris tissue specimen taking from ocular trauma or congenital cataract used as control. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05484050
Study type	Interventional
Source	Assiut University
Contact
Status	Not yet recruiting
Phase	N/A
Start date	September 2022
Completion date	June 2023

View Details

See also
	Status	Clinical Trial	Phase
	Completed	`NCT01240486` - IMPAACT P1073: Study of IRIS for Infants and Children Initiating HAART at Int'l Sites	N/A
	Completed	`NCT03092817` - Adjunctive Corticosteroids for Tuberculous Meningitis in HIV-infected Adults (The ACT HIV Trial)	Phase 3